R&D Systems™ Recombinant Human BCMA/TNFRSF17 Fc Alexa Fluor™ 647 Protein

Description

Recombinant Protein

Measured by flow cytometry for its ability to bind anti-Human BCMA/TNFRSF17 Monoclonal Antibody conjugated beads.The concentration of Recombinant human BCMA/TNFRSF17 Chimera Alexa Fluor™ 647 (Catalog# AFR193) that produces 50% of the binding response is 0.5-5.0 ng/mL.

Specifications

• Accession Number: Q02223.2
• For Use With (Application): Bioactivity
• Formulation: Supplied as a 0.2 μm filtered solution in PBS with BSA as a carrier protein.
• Gene ID (Entrez): 608
• Molecular Weight (g/mol): M.W.-observed: 35-45 kDa, reducing conditions, M.W.-theroretical: 32 kDa (monomer)
• Quantity: 20 μg
• Source: Mouse myeloma cell line, NS0-derived human BCMA/TNFRSF17 protein Human BCMA (Met1-Ala54) (N-terminus) Accession # Q02223.2 IEGRMD Human IgG1 (Pro100-Lys330) (C-terminus)
• Storage Requirements: Protect from light. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 6 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after opening. 3 months, -20°C to -70°C under sterile conditions after opening.
• Endotoxin Concentration: <1.0 EU / 1 μg of the protein by the LAL method.
• Gene Alias: B cell maturation antigen, B-cell maturation protein, BCMAtumor necrosis factor receptor superfamily member 17, BCMB-cell maturation factor, CD269, CD269 antigen, TNFRSF13A, TNFRSF17, tumor necrosis factor receptor superfamily, member 17
• Conjugate: Alexa Fluor 647
• Purity or Quality Grade: >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining.
• Protein: BCMA/TNFRSF17